Literature DB >> 6774203

Investigation of factors determining the optimal glucose infusion rate in total parenteral nutrition.

R R Wolfe, T F O'Donnell, M D Stone, D A Richmand, J F Burke.   

Abstract

We have used the primed constant infusion of U-13C-glucose to study glucose metabolism during conventional total parenteral nutrition (TPN) in five postoperative surgical patients. Glucose production from nonrecycled carbon sources was suppressed to 17% of the basal level at the lowest rate of glucose infusion tested (4 mg/kg x min). Subsequent increases in glucose infusion rate had minimal effect in further suppressing glucose production. Additional nitrogen-sparing effects of glucose when glucose is infused at rates in excess of 4 mg/kg x min must therefore be derived from oxidation of the infused glucose. An increase in the infusion rate from 4 mg/kg x min to 7 mg/kg x min was associated with an increased rate of glucose oxidation, but a further increase in glucose infusion rate (9 mg/kg x min) was without significant effect on glucose oxidation. As the rate of TPN administration (glucose and amino acids) increased, both metabolic rate and RQ rose significantly. Our calculations indicate that the high RQ's observed during the highest glucose infusion rate (X = 1.13) could be attributed to the synthesis of fat from infused glucose, and that about 30% of the increase in VO2 above the basal level could also be attributed to fat synthesis. The progressive increase in the ability to clear glucose from the blood that occurred as TPN progressed was not due to an increase in the rate of oxidation of glucose; we found no correlation between glucose clearance and glucose oxidation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774203     DOI: 10.1016/0026-0495(80)90130-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

1.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

Authors:  A Aarsland; D Chinkes; R R Wolfe
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients.

Authors:  Y Sakurai; A Aarsland; D N Herndon; D L Chinkes; E Pierre; T T Nguyen; B W Patterson; R R Wolfe
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

3.  Nutrition in respiratory failure.

Authors:  G Iapichino
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 4.  A sensible approach to the nutritional support of mechanically ventilated critically ill patients.

Authors:  J W Christman; R W McCain
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 5.  Parenteral nutrition: current status and concepts.

Authors:  G D Phillips; C L Odgers
Journal:  Drugs       Date:  1982-04       Impact factor: 9.546

Review 6.  Medium chain triglycerides and structured lipids as unique nonglucose energy sources in hyperalimentation.

Authors:  E A Mascioli; B R Bistrian; V K Babayan; G L Blackburn
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

Review 7.  Protein sparing therapies in acute illness and obesity: a review of George Blackburn's contributions to nutrition science.

Authors:  Dylan D Thomas; Nawfal W Istfan; Bruce R Bistrian; Caroline M Apovian
Journal:  Metabolism       Date:  2017-12-07       Impact factor: 8.694

8.  Glucose metabolism in a term infant with transient hyperinsulinism and high carbohydrate intake.

Authors:  J B van Goudoever; E J Sulkers; S C Kalhan; P J Sauer
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

9.  Parenteral nutrition: Revisited.

Authors:  Koneru Veera Raghava Chowdary; Pothula Narasimha Reddy
Journal:  Indian J Anaesth       Date:  2010-03

10.  Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury.

Authors:  W G Cioffi; D C Gore; L W Rue; G Carrougher; H P Guler; W F McManus; B A Pruitt
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.